evaluation of variable data independent acquisition (vdia ......target screening of veterinary drugs...

Click here to load reader

Upload: others

Post on 17-Nov-2020

7 views

Category:

Documents


0 download

TRANSCRIPT

  • Evaluation of Variable Data Independent Acquisition (vDIA) Approach for Non-target Screening of Veterinary Drugs in Animal Feed Zhe Zhou, Zheng Jiang; Thermo Fisher Scienti� c, Shanghai, China

    Po

    ster No

    te 64

    42

    6

    Full scan m/z 100 - 1000

    vDIA m/z 495 – 1000

    vDIA m/z 100 - 205

    vDIA m/z 195 - 305

    vDIA m/z 295 - 405

    vDIA m/z 395 - 505

    RT(min)

    0

    100

    200

    300

    400

    500

    600

    700

    800

    900

    1000

    0 2 4 6 8 10 12 14 16 18

    0

    50

    100

    m/z

    Mobile phase

    B%

    Quadrupole HCD Orbitrap

    ddMS2

    Quadrupole HCD Orbitrap

    vDIA

    OrbitrapQuadrupole HCD

    AIF

    200 400 600 800 1000m/z100 300 500

    Full Scan

    RT: 4.00 - 7.00

    4 5 6 7Time (min)0

    50100

    050

    1000

    50100

    050

    100

    Rela

    tive

    Abun

    danc

    e

    050

    1000

    50100

    050

    100 5.65 5.655.685.63

    5.65 5.665.635.695.62

    5.40 5.415.385.465.35

    5.62

    5.45 5.455.435.535.40 5.69

    5.61 5.625.59

    5.655.56

    5.66 5.665.65

    5.69

    5.575.56 5.585.55 5.61

    RT: 4.00 - 7.00

    4 5 6 7Time (min)0

    50100

    050

    1000

    50100

    050

    100

    Rela

    tive

    Abun

    danc

    e

    050

    1000

    50100

    050

    100 5.65

    5.65

    5.365.50

    5.65

    5.435.57

    5.71

    5.66

    5.68

    RT: 4.00 - 7.00

    4 5 6 7Time (min)0

    50100

    050

    1000

    50100

    050

    100

    Rela

    tive

    Abun

    danc

    e

    050

    1000

    50100

    050

    100 5.66 5.645.63 5.68

    5.695.685.705.73

    5.445.43 5.455.39 5.54

    5.675.35

    5.44 5.455.435.545.40 5.67

    5.61 6.39 6.405.60 5.625.58

    5.675.665.685.69

    5.575.56 5.595.61

    386.13043

    150 200 250 300 350 400 450 500 550m/z0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    238.09718

    400.14606285.02039366.98318 516.17285256.08987202.12245154.99007

    422.26361Brombuterol

    2-Amino-5-Benzoyl-Benzimidazole

    SulfachloropyridazineAzure A

    Sarafloxacin hydrochlorideDifluoxacin hydrochloride

    Spiramycin

    Parent ions ddMS2 Product ions vDIA Product ions

    Full scan

    RT:8.023 - 12.469

    9 10 11 12Time (min)0

    20

    40

    60

    80

    1000

    20

    40

    60

    80

    100 10.14

    9.0398.569 9.130 11.3039.903 11.040 11.954

    10.12

    AIF

    vDIA

    11.84

    O

    O

    O

    OH

    OH

    187.0754

    ZearalenoneXIC Product ion 187.0754

    RT:2.250 - 6.787

    2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5Time (min)

    0

    20

    40

    60

    80

    1000

    20

    40

    60

    80

    1003.858

    4.699

    6.396

    4.696

    AIF

    vDIA

    RactopamineXIC Product ion 121.0648

    NH

    OH

    OHOH

    121.0648

    RT:4.432 - 6.887

    4.5 5.0 5.5 6.0 6.5Time (min)

    0

    20

    40

    60

    80

    1000

    20

    40

    60

    80

    1004.924

    6.807

    5.8985.6455.464 6.3786.0774.643

    5.889

    SNH

    N N

    O

    N2H

    O

    O

    O

    SulfadimethoxineXIC Product ion 156.0114

    156.0114

    AIF

    vDIA

    No.

    ofa

    naly

    tes

    Sensitivity

    2

    12

    41

    71

    18

    6

    0

    10

    20

    30

    40

    50

    60

    70

    80

  • 2 Evaluation of Variable Data Independent Acquisition (vDIA) Approach for Non-target Screening of Veterinary Drugs in Animal Feed

    Full scan m/z 100 - 1000

    vDIA m/z 495 – 1000

    vDIA m/z 100 - 205

    vDIA m/z 195 - 305

    vDIA m/z 295 - 405

    vDIA m/z 395 - 505

    RT(min)

    0

    100

    200

    300

    400

    500

    600

    700

    800

    900

    1000

    0 2 4 6 8 10 12 14 16 18

    0

    50

    100

    m/z

    Mobile phase B

    %

    Quadrupole HCD Orbitrap

    ddMS2

    Quadrupole HCD Orbitrap

    vDIA

    OrbitrapQuadrupole HCD

    AIF

    200 400 600 800 1000m/z100 300 500

    Full Scan

    RT: 4.00 - 7.00

    4 5 6 7Time (min)0

    50100

    050

    1000

    50100

    050

    100

    Rela

    tive

    Abun

    danc

    e

    050

    1000

    50100

    050

    100 5.65 5.655.685.63

    5.65 5.665.635.695.62

    5.40 5.415.385.465.35

    5.62

    5.45 5.455.435.535.40 5.69

    5.61 5.625.59

    5.655.56

    5.66 5.665.65

    5.69

    5.575.56 5.585.55 5.61

    RT: 4.00 - 7.00

    4 5 6 7Time (min)0

    50100

    050

    1000

    50100

    050

    100

    Rela

    tive

    Abun

    danc

    e

    050

    1000

    50100

    050

    100 5.65

    5.65

    5.365.50

    5.65

    5.435.57

    5.71

    5.66

    5.68

    RT: 4.00 - 7.00

    4 5 6 7Time (min)0

    50100

    050

    1000

    50100

    050

    100

    Rela

    tive

    Abun

    danc

    e

    050

    1000

    50100

    050

    100 5.66 5.645.63 5.68

    5.695.685.705.73

    5.445.43 5.455.39 5.54

    5.675.35

    5.44 5.455.435.545.40 5.67

    5.61 6.39 6.405.60 5.625.58

    5.675.665.685.69

    5.575.56 5.595.61

    386.13043

    150 200 250 300 350 400 450 500 550m/z0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    238.09718

    400.14606285.02039366.98318 516.17285256.08987202.12245154.99007

    422.26361Brombuterol

    2-Amino-5-Benzoyl-Benzimidazole

    SulfachloropyridazineAzure A

    Sarafloxacin hydrochlorideDifluoxacin hydrochloride

    Spiramycin

    Parent ions ddMS2 Product ions vDIA Product ions

    Full scan

    RT:8.023 - 12.469

    9 10 11 12Time (min)0

    20

    40

    60

    80

    1000

    20

    40

    60

    80

    100 10.14

    9.0398.569 9.130 11.3039.903 11.040 11.954

    10.12

    AIF

    vDIA

    11.84

    O

    O

    O

    OH

    OH

    187.0754

    ZearalenoneXIC Product ion 187.0754

    RT:2.250 - 6.787

    2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5Time (min)

    0

    20

    40

    60

    80

    1000

    20

    40

    60

    80

    1003.858

    4.699

    6.396

    4.696

    AIF

    vDIA

    RactopamineXIC Product ion 121.0648

    NH

    OH

    OHOH

    121.0648

    RT:4.432 - 6.887

    4.5 5.0 5.5 6.0 6.5Time (min)

    0

    20

    40

    60

    80

    1000

    20

    40

    60

    80

    1004.924

    6.807

    5.8985.6455.464 6.3786.0774.643

    5.889

    SNH

    N N

    O

    N2H

    O

    O

    O

    SulfadimethoxineXIC Product ion 156.0114

    156.0114

    AIF

    vDIA

    No.

    of a

    naly

    tes

    Sensitivity

    2

    12

    41

    71

    18

    6

    0

    10

    20

    30

    40

    50

    60

    70

    80

  • PN64426-EN 08/16S

    Full scan m/z 100 - 1000

    vDIA m/z 495 – 1000

    vDIA m/z 100 - 205

    vDIA m/z 195 - 305

    vDIA m/z 295 - 405

    vDIA m/z 395 - 505

    RT(min)

    0

    100

    200

    300

    400

    500

    600

    700

    800

    900

    1000

    0 2 4 6 8 10 12 14 16 18

    0

    50

    100

    m/z

    Mobile phase

    B%

    Quadrupole HCD Orbitrap

    ddMS2

    Quadrupole HCD Orbitrap

    vDIA

    OrbitrapQuadrupole HCD

    AIF

    200 400 600 800 1000m/z100 300 500

    Full Scan

    RT: 4.00 - 7.00

    4 5 6 7Time (min)0

    50100

    050

    1000

    50100

    050

    100

    Rela

    tive

    Abun

    danc

    e

    050

    1000

    50100

    050

    100 5.65 5.655.685.63

    5.65 5.665.635.695.62

    5.40 5.415.385.465.35

    5.62

    5.45 5.455.435.535.40 5.69

    5.61 5.625.59

    5.655.56

    5.66 5.665.65

    5.69

    5.575.56 5.585.55 5.61

    RT: 4.00 - 7.00

    4 5 6 7Time (min)0

    50100

    050

    1000

    50100

    050

    100

    Rela

    tive

    Abun

    danc

    e

    050

    1000

    50100

    050

    100 5.65

    5.65

    5.365.50

    5.65

    5.435.57

    5.71

    5.66

    5.68

    RT: 4.00 - 7.00

    4 5 6 7Time (min)0

    50100

    050

    1000

    50100

    050

    100

    Rela

    tive

    Abun

    danc

    e

    050

    1000

    50100

    050

    100 5.66 5.645.63 5.68

    5.695.685.705.73

    5.445.43 5.455.39 5.54

    5.675.35

    5.44 5.455.435.545.40 5.67

    5.61 6.39 6.405.60 5.625.58

    5.675.665.685.69

    5.575.56 5.595.61

    386.13043

    150 200 250 300 350 400 450 500 550m/z0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    238.09718

    400.14606285.02039366.98318 516.17285256.08987202.12245154.99007

    422.26361Brombuterol

    2-Amino-5-Benzoyl-Benzimidazole

    SulfachloropyridazineAzure A

    Sarafloxacin hydrochlorideDifluoxacin hydrochloride

    Spiramycin

    Parent ions ddMS2 Product ions vDIA Product ions

    Full scan

    RT:8.023 - 12.469

    9 10 11 12Time (min)0

    20

    40

    60

    80

    1000

    20

    40

    60

    80

    100 10.14

    9.0398.569 9.130 11.3039.903 11.040 11.954

    10.12

    AIF

    vDIA

    11.84

    O

    O

    O

    OH

    OH

    187.0754

    ZearalenoneXIC Product ion 187.0754

    RT:2.250 - 6.787

    2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5Time (min)

    0

    20

    40

    60

    80

    1000

    20

    40

    60

    80

    1003.858

    4.699

    6.396

    4.696

    AIF

    vDIA

    RactopamineXIC Product ion 121.0648

    NH

    OH

    OHOH

    121.0648

    RT:4.432 - 6.887

    4.5 5.0 5.5 6.0 6.5Time (min)

    0

    20

    40

    60

    80

    1000

    20

    40

    60

    80

    1004.924

    6.807

    5.8985.6455.464 6.3786.0774.643

    5.889

    SNH

    N N

    O

    N2H

    O

    O

    O

    SulfadimethoxineXIC Product ion 156.0114

    156.0114

    AIF

    vDIA

    No.

    of a

    naly

    tes

    Sensitivity

    2

    12

    41

    71

    18

    6

    0

    10

    20

    30

    40

    50

    60

    70

    80